Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1999-11-16
2000-11-07
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514547, A61K 31205, A61K 31225
Patent
active
061437859
ABSTRACT:
The use of lower alkanoyl L-carnitines is disclosed for preparing pharmaceutical compositions (particularly foams and enemas) for treating chronic inflammatory bowel diseases, in particular ulcerative colitis.
REFERENCES:
patent: 4663352 (1987-05-01), Onofri
patent: 5998474 (1999-12-01), Cavazza
Harrison's Principles of Internal Medicine, 8th ed. (McGrawHill) chap. 291, p. 1560, 1977.
Morrison & Boyd, Organic Chemistry, Fifth Edition, pp. 858-859 (1990).
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
Spivack Phyllis G.
LandOfFree
Use of alkanoyl L-carnitines for the therapeutical treatment of does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of alkanoyl L-carnitines for the therapeutical treatment of , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of alkanoyl L-carnitines for the therapeutical treatment of will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1641604